Dual antiplatelet therapy and drug eluting stents: A marriage of convenience

被引：6
|
作者：
Benezet-Mazuecos J. [1 ]
Ibanez B. [1 ]
Badimon J.J. [1 ]
机构：
[1] Cardiovascular Biology Research Laboratory, Cardiovascular Institute, Mount Sinai School of Medicine, New York, NY
来源：
Thrombosis Journal | / 5卷 / 1期
关键词：
Sirolimus; Stent Thrombosis; Bare Metal Stents; Dual Antiplatelet Therapy; Sirolimus Elute Stent;
D O I：
10.1186/1477-9560-5-15
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
相关论文
共 50 条
  • [41] Dual antiplatelet therapy in the drug-eluting stent era
    Wallentim, Lars
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2008, 10 (0D) : D38 - D44
  • [42] Response to letter: Duration of dual antiplatelet therapy following drug-eluting coronary stents: Longer or shorter?
    Cockburn, James
    Hildick-Smith, David
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 202 : 938 - 938
  • [43] Long term dual antiplatelet therapy after drug eluting stents: a meta-analysis of randomised studies
    Ferrante, G.
    Pisaniello, M.
    Stefanini, G. G.
    Pagnotta, P.
    Reimers, B.
    EUROPEAN HEART JOURNAL, 2016, 37 : 31 - 31
  • [44] Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy
    Kereiakes, Dean J.
    Yeh, Robert W.
    Massaro, Joseph M.
    Driscoll-Shempp, Priscilla
    Cutlip, Donald E.
    Steg, P. Gabriel
    Gershlick, Anthony H.
    Darius, Harald
    Meredith, Ian T.
    Ormiston, John
    Tanguay, Jean-Francois
    Windecker, Stephan
    Garratt, Kirk N.
    Kandzari, David E.
    Lee, David P.
    Simon, Daniel I.
    Iancu, Adrian Corneliu
    Trebacz, Jaroslaw
    Mauri, Laura
    JACC-CARDIOVASCULAR INTERVENTIONS, 2015, 8 (12) : 1552 - 1562
  • [45] Importance of Short-Term Neointimal Coverage of Drug-Eluting Stents in the Duration of Dual Antiplatelet Therapy
    Fluder-Wlodarczyk, Joanna
    Pawlowski, Slawomir
    Chuchra, Piotr J.
    Pawlowski, Tomasz
    Wojakowski, Wojciech
    Gasior, Pawel
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (06)
  • [46] Will this trial change my practice? The Dual Antiplatelet Therapy (DAPT) study-12 or 30 months of dual antiplatelet therapy after drug-eluting stents
    Grundeken, Maik J.
    Lansky, Alexandra
    Tanguay, Jean-Francois
    Gershlick, Anthony
    Baumbach, Andreas
    Cuisset, Thomas
    EUROINTERVENTION, 2015, 11 (03) : 364 - 365
  • [47] Drug-eluting stents and contemporary dual antiplatelet therapy in revascularized STEMI. The times they are a-changin'?
    Rincon, Luis M.
    Villacorta, Eduardo
    Sanchez, Pedro L.
    REVISTA ESPANOLA DE CARDIOLOGIA, 2022, 75 (08): : 623 - 625
  • [48] The optimal duration of dual antiplatelet therapy after implantation of drug-eluting coronary stents: an unanswered question
    Aurigemma, Cristina
    Burzotta, Francesco
    Trani, Carlo
    CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2017, 7 : S91 - S94
  • [49] Subacute thrombosis of drug-eluting-stents in a patient with a mechanical aortic prosthesis:: the importance of dual antiplatelet therapy
    Lobato, Miguel Angel Navas
    Sanchez-Recalde, Angel
    Reyes, Roberto Martin
    Gomez, Raul Moreno
    MEDICINA CLINICA, 2007, 129 (10): : 399 - 399
  • [50] DUAL ANTIPLATELET THERAPY UTILIZATION AND CARDIOVASCULAR OUTCOMES AMONG BLACK AND WHITE PATIENTS TREATED WITH DRUG ELUTING STENTS
    Sullivan, Lonnie T.
    Mulder, Hillary
    Chiswell, Karen
    Shaw, Linda
    Wang, Tracy
    Thomas, Kevin
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 1017 - 1017
12345